NeueHealth, Inc. (NEUE) Financial Statements (2026 and earlier)

Company Profile

Business Address 9250 NW 36TH STREET
DORAL, FL 33178
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 6324 - Hospital and Medical Service Plans (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments93,16693,564479,5311,255,014
Cash and cash equivalent83,29587,299466,3251,061,179
Short-term investments9,8716,26513,206193,835
Receivables36,59439,08473,605113,474
Disposal group, including discontinued operation173,006822,5702,783,474 
Other undisclosed current assets131,882133,709234,024291,712
Total current assets:434,6481,088,9273,570,6341,660,200
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization11,24014,49942,59638,344
Long-term investments and receivables   5,401675,192
Long-term investments   5,401675,192
Intangible asset, including goodwill, after accumulated amortization71,06493,2381,009,1611,179,000
Goodwill   760,078835,140
Intangible asset, excluding goodwill, after accumulated amortization71,06493,238249,083343,860
Other noncurrent assets27,43128,81637,26045,603
Total noncurrent assets:109,735136,5531,094,4181,938,139
TOTAL ASSETS:544,3831,225,4804,665,0523,598,339
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,29811,84167,854118,140
Accounts payable6,29811,84167,854118,140
Debt4,000303,947303,947155,000
Disposal group, including discontinued operation  699,7582,783,474 
Other liabilities79,20079,856121,424207,238
Other undisclosed current liabilities620,730295,855411,9951,802,440
Total current liabilities:710,2281,391,2573,688,6942,282,818
Noncurrent Liabilities
Long-term debt and lease obligation202,614   
Long-term debt, excluding current maturities202,614   
Liabilities, other than long-term debt17,64944,87236,67341,994
Other liabilities17,64922,44136,67341,994
Operating lease, liability  22,431  
Other undisclosed noncurrent liabilities  43,969  
Total noncurrent liabilities:220,26388,84136,67341,994
Total liabilities:930,4911,480,0983,725,3672,324,812
Temporary equity, including noncontrolling interest968,9971,009,3251,140,175128,407
Equity
Equity, attributable to parent(1,355,105)(1,263,943)(200,490)1,145,120
Common stock116363
Treasury stock, value(12,000)(12,000)(12,000)(12,000)
Additional paid in capital3,099,4233,056,0272,972,2712,861,243
Accumulated other comprehensive loss  (122)(4,429)(3,335)
Accumulated deficit(4,442,529)(4,307,849)(3,156,395)(1,700,851)
Total equity:(1,355,105)(1,263,943)(200,490)1,145,120
TOTAL LIABILITIES AND EQUITY:544,3831,225,4804,665,0523,598,339

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenues936,6571,160,8022,412,0304,029,389
Premiums earned, net   1,764,9493,902,714
Cost of revenue
(Policyholder Benefits and Claims Incurred, Net)
(742,140)(996,582)  
Gross profit:194,517164,2202,412,0304,029,389
Operating expenses(1,044,067)(1,737,798)(3,034,278)(5,227,545)
Other undisclosed operating income742,140996,582  
Operating loss:(107,410)(576,996)(622,248)(1,198,156)
Nonoperating income
(Other Nonoperating income)
   7841,226
Interest and debt expense11,610(38,203)(12,821)(7,956)
Loss from continuing operations before equity method investments, income taxes:(95,800)(615,199)(634,285)(1,204,886)
Other undisclosed loss from continuing operations before income taxes(3,661)(13,971)  
Loss from continuing operations before income taxes:(99,461)(629,170)(634,285)(1,204,886)
Income tax expense (benefit)(2,597)1,428(3,680)26,521
Other undisclosed income (loss) from continuing operations(86,613)65,209  
Loss from continuing operations:(188,671)(562,533)(637,965)(1,178,365)
Loss before gain (loss) on sale of properties:(1,178,365)
Loss from discontinued operations   (720,241) 
Other undisclosed net income (loss)88,954(703,275)(1,674) 
Net loss:(99,717)(1,265,808)(1,359,880)(1,178,365)
Net income (loss) attributable to noncontrolling interest(9,259)73,199 (6,497)
Other undisclosed net income (loss) attributable to parent(25,704)41,155(95,664) 
Net loss attributable to parent:(134,680)(1,151,454)(1,455,544)(1,184,862)
Other undisclosed net loss available to common stockholders, basic(51,650)(49,145)(39,687) 
Net loss available to common stockholders, diluted:(186,330)(1,200,599)(1,495,231)(1,184,862)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(99,717)(1,265,808)(1,359,880)(1,178,365)
Net loss attributable to redeemable noncontrolling interest(9,259)
Other comprehensive income (loss) 1224,307(1,094)(5,761)
Comprehensive loss:(99,595)(1,261,501)(1,360,974)(1,184,126)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(34,963)114,354(95,664)(6,497)
Comprehensive loss, net of tax, attributable to parent:(134,558)(1,147,147)(1,456,638)(1,190,623)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: